These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38352821)

  • 1. Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma.
    Zhang C; Guo Z; Jing Z
    Int J Nanomedicine; 2024; 19():1351-1362. PubMed ID: 38352821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma-derived Exosomal miR-25-3p and miR-23b-3p as Predictors of Response to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.
    Jing Z; Guo Z; Zhang C
    Technol Cancer Res Treat; 2024; 23():15330338241289520. PubMed ID: 39380461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of circulating exosomes-based liquid biopsy for esophageal cancer.
    Zhao A; Guo L; Xu J; Zheng L; Guo Z; Ling Z; Wang L; Mao W
    Cancer Med; 2019 Jul; 8(7):3566-3574. PubMed ID: 31099496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
    Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
    Li L; Sun J; Liu N; Yu R; Zhang J; Pang J; Ou Q; Yin Y; Cui J; Yao X; Zhao R; Shao Y; Yuan S; Yu J
    Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):382-394. PubMed ID: 36167753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
    BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SDF-1α predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy.
    Chen YH; Lu HI; Wang YM; Lo CM; Chou SY; Li SH
    Biomed J; 2022 Jun; 45(3):522-532. PubMed ID: 35817708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.
    Matsumoto Y; Kano M; Akutsu Y; Hanari N; Hoshino I; Murakami K; Usui A; Suito H; Takahashi M; Otsuka R; Xin H; Komatsu A; Iida K; Matsubara H
    Oncol Rep; 2016 Nov; 36(5):2535-2543. PubMed ID: 27599779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative CT evaluation after two cycles of induction chemotherapy to predict prognosis of patients with locally advanced oesophageal squamous cell carcinoma before undergoing definitive chemoradiotherapy/radiotherapy.
    Yan S; Shi YJ; Liu C; Li XT; Zhao B; Wei YY; Shen L; Lu ZH; Sun YS
    Eur Radiol; 2023 Jan; 33(1):380-390. PubMed ID: 35927466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.
    Zhang T; Guo Z; Chen X; Dong J; Jiang H; Tang P; Wang P; Qian D; Zhang W; Pang Q
    Radiat Oncol; 2022 Aug; 17(1):148. PubMed ID: 35999608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
    Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
    Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
    Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
    Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.
    Kang M; Ren M; Li Y; Fu Y; Deng M; Li C
    J Exp Clin Cancer Res; 2018 Jul; 37(1):171. PubMed ID: 30049286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and detection of plasma extracellular vesicles-derived biomarkers for esophageal squamous cell carcinoma diagnosis.
    Zhu Q; Xu H; Huang L; Luo J; Li H; Yang R; Liu X; Liu F
    Biosens Bioelectron; 2023 Apr; 225():115088. PubMed ID: 36739741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy.
    Qiu J; Yang J; Yu Y; Wang Z; Lin H; Ke D; Zheng H; Li J; Yao Q
    BMC Cancer; 2023 Jun; 23(1):597. PubMed ID: 37380982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.
    Bulibu J; Wang W; Tang Y; Li N; Saifuding K
    Pathol Oncol Res; 2019 Jan; 25(1):421-427. PubMed ID: 29270777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
    Tong YS; Zhou XL; Wang XW; Wu QQ; Yang TX; Lv J; Yang JS; Zhu B; Cao XF
    J Transl Med; 2014 Aug; 12():233. PubMed ID: 25169763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study.
    He W; Wang C; Wu L; Wan G; Li B; Han Y; Li H; Leng X; Du K; Chen H; Wang Q; Peng L
    Front Immunol; 2022; 13():853922. PubMed ID: 35720312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.